Smooth Metric Adjusted Skew Information Rates

Metric adjusted skew information, induced from quantum Fisher information, is a well-known family of resource measures in the resource theory of asymmetry. However, its asymptotic rates are not valid asymmetry monotone since it has an asymptotic discontinuity. We here introduce a new class of asymmetry measures with the smoothing technique, which we term smooth metric adjusted skew information. We prove that its asymptotic sup- and inf-rates are valid asymptotic measures in the resource theory of asymmetry. Furthermore, it is proven that the smooth metric adjusted skew information rates provide a lower bound for the coherence cost and an upper bound for the distillable coherence.Comment: 21 page

Beyond i.i.d. in the Resource Theory of Asymmetry: An Information-Spectrum Approach for Quantum Fisher Information

Energetic coherence is indispensable for various operations, including precise measurement of time and acceleration of quantum manipulations. Since energetic coherence is fragile, it is essential to understand the limits in distillation and dilution to restore damage. The resource theory of asymmetry (RTA) provides a rigorous framework to investigate energetic coherence as a resource to break time-translation symmetry. Recently, in the i.i.d. regime where identical copies of a state are converted into identical copies of another state, it has been shown that the convertibility of energetic coherence is governed by a standard measure of energetic coherence, called the quantum Fisher information (QFI). This fact means that QFI in the theory of energetic coherence takes the place of entropy in thermodynamics and entanglement entropy in entanglement theory. However, distillation and dilution in realistic situations take place in regimes beyond i.i.d., where quantum states often have complex correlations. Unlike entanglement theory, the conversion theory of energetic coherence in pure states in the non-i.i.d. regime has been an open problem. In this Letter, we solve this problem by introducing a new technique: an information-spectrum method for QFI. Two fundamental quantities, coherence cost and distillable coherence, are shown to be equal to the spectral QFI rates for arbitrary sequences of pure states. As a consequence, we find that both entanglement theory and RTA in the non-i.i.d. regime are understood in the information-spectrum method, while they are based on different quantities, i.e., entropy and QFI, respectively.Comment: 25 pages, 3 figure

Reactivation of Alternate Bars to Increased Sediment Supply

Source: ICHE Conference Archive - https://mdi-de.baw.de/icheArchive

Evaluation of Small Business Innovation Research Programs in Japan

The Small Business Innovation Research (SBIR) program conducted by the Japanese government is intended to enable the rapid growth of small firms. Using comprehensive empirical data, this study examines the performances of firms that are directly affected by the program. First, to provide an outline, this study compares the changes in sales, employment, and the number of patents between SBIR awardees and matched firms. It cannot be shown that SBIR awardees have better performance using those indices. Second, this study conducts regression analyses to control for firm sizes, multiple awards, technological levels, the value of venture capital in a region, and population in regions. As a result, this study does not find that SBIR awardees have advantages after applying these detailed controls. This study shows that further detailed investigation is required to prove the benefit of the SBIR program

Dexterous hand-arm coordinated manipulation using active body-environment contact

Abstract-Human-symbiotic humanoid robots that can perform tasks dexterously using their hands are needed in our homes, welfare facilities, and other places. To improve their task performance, we propose a motion control scheme aimed at appropriately coordinated hand and arm motions. By observing human manual tasks, we identified active body-environment contact as a kind of human manual skill and devised a motion control scheme based on it. We also analyzed the effectiveness of active body-environment contact in glass-placing and drawer-opening tasks. We validated our motion control scheme through actual tests on a prototype human-symbiotic humanoid robot

Radical polymerization by a supramolecular catalyst: cyclodextrin with a RAFT reagent

Supramolecular catalysts have received a great deal of attention because they improve the selectivity and efficiency of reactions. Catalysts with host molecules exhibit specific reaction properties and recognize substrates via host–guest interactions. Here, we examined radical polymerization reactions with a chain transfer agent (CTA) that has α-cyclodextrin (α-CD) as a host molecule (α-CD-CTA). Prior to the polymerization of N,N-dimethylacrylamide (DMA), we investigated the complex formation of α-CD with DMA. Single X-ray analysis demonstrated that α-CD includes DMA inside its cavity. When DMA was polymerized in the presence of α-CD-CTA using 2,2\u27-azobis[2-(2-imidazolin-2-yl)propane dihydrochloride (VA-044) as an initiator in an aqueous solution, poly(DMA) was obtained in good yield and with narrow molecular weight distribution. In contrast, the polymerization of DMA without α-CD-CTA produced more widely distributed polymers. In the presence of 1,6-hexanediol (C6 diol) which works as a competitive molecule by being included in the α-CD cavity, the reaction yield was lower than that without C6 diol

Comparison of treatment in patients

The terminal elimination half-life (t1/2) of empagliflozin is 13.1 hours. Accordingly, we hypothesized that the administration of empagliflozin every other day might improve glycemic control in patients with type 2 diabetes mellitus, not being inferior to the therapy every day. We investigated the clinical effects and safety of the addition of empagliflozin every day or every other day to type 2 diabetic patients with a poor control in glycemia. Thirteen Japanese patients diagnosed as type 2 diabetes mellitus recruited to this study. Subjects were divided into two groups ; one was treatment with 10 mg of empagliflozin every day (Group A), the other was 10 mg of empagliflozin every other day (Group B). The comparable study of multiple clinical indexes between the 2 groups was made before and 8, 16, and 24 weeks after the treatment. After the treatment for 24 weeks, the HbA1c level was decreased both in group A (from 7.5%±1.1% to 6.5%±0.8%) and in group B (from 7.6%±0.8% to 7.2%±0.5%). This pilot trial suggested the possibility of 10-mg every other day administration with empagliflozin for Japanese patients with type 2 diabetes mellitus